Biotechnology - Pharmaceutical, Patents

Filter

Current filters:

PharmaceuticalPatents

Popular Filters

1 to 25 of 38 results

US Court denies re-hearing of Arzerra patent case

16-07-2013

Danish drugmaker Genmab (OMX: GEN) says that the US Court of Appeals for the Federal Circuit has declined…

ArzerraBiogen IdecBiotechnologyGenentechGenmabGlaxoSmithKlineLegalNorth AmericaOncologyPatentsPharmaceutical

Market access barriers for multinationals, but Argentina still offers attractive pharma opportunities

31-05-2013

Several barriers impede market access but the regulatory landscape in Argentina is changing and attractive…

BiotechnologyMarkets & MarketingPatentsPharmaceuticalRegulationSouth America

Europe falling behind USA and China as attractive for life sciences sector

22-04-2013

Intellectual property specialists Marks & Clerk's latest Life Sciences Report unveils the changing landscape…

BiotechnologyFinancialGlobalPatentsPharmaceuticalRegulationResearch

Australian Pharma Patent Review releases draft report for comment

18-04-2013

The Pharmaceutical Patent Review, conducted by an intellectual property Australia-appointed panel, has…

Asia-PacificBiotechnologyPatentsPharmaceutical

Vision for "better health through research" in Australia set out in new report

05-04-2013

Australian Minister for Health Tanya Plibersek on April 5 released the report of the McKeon Review -…

Asia-PacificBiotechnologyFinancialPatentsPharmaceuticalResearch

Business faces "fundamental change" in protecting inventions in the USA

15-03-2013

From Saturday, March 16, organizations looking to protect their inventions in the USA will face significantly…

BiotechnologyNorth AmericaPatentsPharmaceutical

Call for strong Trans-Pacific intellectual property framework from PhRMA

05-03-2013

The Pharmaceutical Research and Manufacturers of America (PhRMA) this week called on nations participating…

Asia-PacificBiotechnologyNorth AmericaPatentsPharmaceuticalSouth America

UK government moves to cut red tape to benefit R&D for new drugs

27-02-2013

The UK government yesterday announced a change to the Patents Act which will help the UK's world class…

BiotechnologyEuropePatentsPharmaceuticalRegulationResearch

After 30 years of talking, Parliament finally approves EU unitary patent rules

20-02-2013

After over 30 years of talks, in three separate voting sessions, Members of the European Parliament (MEPs)…

BiotechnologyEuropePatentsPharmaceutical

New approach to drug discovery urged by US academician

17-02-2013

Garret FitzGerald, chairman of the Department of Pharmacology and Director of the Institute for Translational…

BiotechnologyFinancialNorth AmericaPatentsPharmaceuticalResearch

Regulatory news for Hyperion's Ravicti and Seattle Genetics' Adcetris

04-02-2013

The US Food and Drug Administration on Friday approved Hyperion Therapeutics' (Nasdaq: HPTX) Ravicti…

AdcetrisBiotechnologyHyperion TherapeuticsNorth AmericaOncologyPatentsPharmaceuticalRare diseasesRavictiRegulationSeattle Genetics

Australian patent length too short, says AusBiotech submission to Patent Review

24-01-2013

Trade group AusBiotech has made a submission in response to the Australian Pharmaceutical Patents Review's…

Asia-PacificBiotechnologyPatentsPharmaceuticalResearch

Australia's Productivity Commission releases draft report on compulsory licensing of patents

10-01-2013

After reviewing the compulsory licensing provisions in the patents system, Australia's Productivity Commission…

Asia-PacificBiotechnologyPatentsPharmaceutical

European Parliament approves unitary patent rules

12-12-2012

Following the historic vote yesterday in the European Union Parliament to approve the unitary patent…

BiotechnologyEuropeLegalPatentsPharmaceutical

EMA workshop on access to clinical-trial data and transparency kicks off process towards proactive publication of data

26-11-2012

"The European Medicines Agency is committed to proactive publication of clinical-trial data, once the…

BiotechnologyEuropePatentsPharmaceuticalRegulationResearch

"New" CDER Exclusivity Board focuses on clarity and consistency of exclusivity decisions

07-11-2012

The US Food and Drug Administration recently announced that the agency has established within the Center…

BiotechnologyLegalNorth AmericaPatentsPharmaceuticalRegulation

UK govt sets out proposals to cut risks for pharmaceutical research

24-10-2012

A new consultation launched yesterday by the Department for Business, Innovation & Skills (BIS) sets…

BiotechnologyEuropePatentsPharmaceuticalRegulationResearch

Australian govt details another review on patents

16-10-2012

The Australian government has announced the commission of an expert panel to review the "appropriateness…

Asia-PacificBiotechnologyPatentsPharmaceuticalPolitics

Time to consider longer patent terms, says Medicines Australia

15-10-2012

A new federal government review of Australia's patent system, announced yesterday, should consider the…

Asia-PacificBiotechnologyPatentsPharmaceuticalPolitics

EFPIA welcomes Commission policy strategy agenda to strengthen Pharma competitiveness

12-10-2012

The European Federation of Pharmaceutical Industries and Associations (EFPIA) welcomes the European Commission…

BiotechnologyEuropeMarkets & MarketingPatentsPharmaceuticalPoliticsPricing

Australian government proposes "tough new standards" for Innovation Patents

27-09-2012

Australia's federal government said in media release this week that it is "considering tough new standards…

Asia-PacificBiotechnologyPatentsPharmaceuticalPolitics

Australian Productivity Commission reviews compulsory licensing in the patents system

30-08-2012

The Australian Productivity Commission's review into compulsory licensing in the patents system is now…

Asia-PacificBiotechnologyLicensingPatentsPharmaceutical

New Zealand pharma urged to capturing value from innovation

30-07-2012

New Zealand's innovative companies and research community must protect their breakthroughs, for the country…

Asia-PacificBiotechnologyPatentsPharmaceuticalResearch

Global pharmaceutical approvals moderate as patent cliff peaks, says Fitch

26-07-2012

The Food and Drug Administration will approve fewer novel drugs in 2012 compared to 2011 while the industry…

BiotechnologyNorth AmericaPatentsPharmaceuticalRegulation

1 to 25 of 38 results

Back to top